Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Patient Portal Now Available As a Cloud Service

By Medimaging International staff writers
Posted on 03 Mar 2013
Print article
A new patient portal encourages patients to securely access, share, and manage their medical images and radiology reports with healthcare providers. It also positions US healthcare providers to meet stage 2 meaningful use (MU) requirements. The portal will be available as a cloud service in March 2013.

Implementing the portal as a Vue Cloud Service, developed by Carestream Health (Rochester, NY, USA), provides the flexibility of a monthly fee, and it can accommodate more users without additional network expansions. Carestream manages remote access, networking requirements and security procedures for users of its cloud services, while also addressing regulatory compliance and service uptime.

MyVue is also available as an on-site portal for users of Carestream’s Vue picture archiving and communication system (PACS) and Vue Archive, a vendor-neutral archiving solution that supports third-party PACS platforms.

The Ferrara Hospital (Ferrara, Italy) conducted an on-site trade trial of the MyVue patient portal as an on-site deployment. The hospital serves a population of more than 350,000 and conducts about 150,000 radiographic scans yearly. “MyVue is very attractive for patients because it enables them to have immediate access to their reports and images from their homes. More than 98% of our patients who participated in the trial were so enthusiastic about the product that they decided to continue using it,” said Giorgio Benea, the hospital’s director of diagnostic imaging. “In addition to providing a more efficient way to deliver imaging data to patients, our hospital gains a favorable reputation for deploying truly innovative technology.”

When patients arrived at admissions, they were offered the option to access imaging exam findings using the new patient portal. Patients that accepted received a password and links to access their own personal web page that contained their exams.

“MyVue helps empower patients to play a greater role in their medical care and gives healthcare providers an important tool in building patient satisfaction and loyalty,” said Cristine Kao, Carestream’s global marketing manager for Healthcare Information Solutions. “And since it’s so convenient for physicians to use, MyVue can help enhance referral volumes.”

Ferrara patients found the MyVue portal easy to use. “The MyVue portal requires no special knowledge of computers or applications, since each section has clear directions to guide users,” Dr. Benea said. By clicking on intuitive icons, patients can share an imaging exam with physicians and can also download the files via the web.

The MyVue portal e-mails a secure login to each patient, and medical images and reports can be accessed through the secure login from a variety of Web-browser enabled devices. No software downloads are required for patients or physicians. MyVue’s HTML5 viewer can be deployed on web-enabled devices such as the iPad and complements Vue Motion, Carestream’s vendor-independent image viewer for clinicians and referring physicians. Both MyVue and Vue Motion can help increase referring physicians’ approval and boosts the exchange of imaging exams.

Related Links:
Carestream Health


Print article
Radcal

Channels

Nuclear medicine

view channel
Image: The newly approved PET imaging agent Fluciclovine (18F) anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (FACBC) is a synthetic amino acid (Photo courtesy of Blue Earth Diagnostics).

New PET Imaging Agent for Recurrent Prostate Cancer Approved by US FDA

The US Food and Drug Administration (FDA) has approved the first PET imaging molecular imaging agent for use in patients who have suspected recurrent prostate cancer. The agent is indicated for use... Read more

Industry News

view channel

Nuclear Medicine Market Exhibits Slow Growth

The slow growth of the global nuclear medicine market is driven by lower revenues from technetium-99m-related products and unfavorable USD exchange rates against major currencies. These are the latest findings of Medraysintell (Louvain-la-Neuve, Belgium), a provider of strategic intelligence for radiation healthcare.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.